These findings are in agreement with our results, which showed a stable nonlinear relationship between GPR and prognosis using RCS models, further underscoring the significance of GPR as a prognostic biomarker in MM-TBI. This evidence concerns the gene ALDH18A1 and Miyoshi myopathy.